LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 154

Search options

  1. Article ; Online: Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines.

    Idilman, Ramazan

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

    2017  Volume 28, Issue 6, Page(s) 518–521

    Abstract: The morbidity and mortality of hepatitis B virus-related liver disease are linked to the persistence of the hepatitis B virus replication. Viral suppression with antiviral therapy has been shown to provide clinical benefits. Several special groups of ... ...

    Abstract The morbidity and mortality of hepatitis B virus-related liver disease are linked to the persistence of the hepatitis B virus replication. Viral suppression with antiviral therapy has been shown to provide clinical benefits. Several special groups of patients with hepatitis B virus infection require special attention. In this brief report, based on European Association for the Study of the Liver 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection, the current optimal management of special patient groups with hepatitis B virus infection is summarized.
    MeSH term(s) Antiviral Agents/therapeutic use ; Disease Management ; Hepatitis B/drug therapy ; Hepatitis B/virology ; Hepatitis B virus/physiology ; Humans ; Virus Replication/drug effects
    Chemical Substances Antiviral Agents
    Language English
    Publishing date 2017-11
    Publishing country Turkey
    Document type Journal Article ; Practice Guideline
    ZDB-ID 1340275-4
    ISSN 2148-5607 ; 1300-4948
    ISSN (online) 2148-5607
    ISSN 1300-4948
    DOI 10.5152/tjg.2017.171017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The summarized of EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

    Idilman, Ramazan

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

    2017  Volume 28, Issue 5, Page(s) 412–416

    MeSH term(s) Antiviral Agents/therapeutic use ; DNA, Viral/blood ; Drug Resistance, Viral ; Hepatitis B/drug therapy ; Hepatitis B virus/genetics ; Humans ; Interferon-alpha/therapeutic use ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/virology ; Polyethylene Glycols/therapeutic use ; Recombinant Proteins/therapeutic use ; Sustained Virologic Response
    Chemical Substances Antiviral Agents ; DNA, Viral ; Interferon-alpha ; Recombinant Proteins ; Polyethylene Glycols (30IQX730WE) ; peginterferon alfa-2a (Q46947FE7K)
    Language English
    Publishing date 2017
    Publishing country Turkey
    Document type Journal Article ; Practice Guideline
    ZDB-ID 1340275-4
    ISSN 2148-5607 ; 1300-4948
    ISSN (online) 2148-5607
    ISSN 1300-4948
    DOI 10.5152/tjg.2017.20817
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Hepatitis D Infection in Asia: A Perspective From an Endemic Region.

    Gokcan, Hale / Idilman, Ramazan

    Clinical liver disease

    2021  Volume 18, Issue 1, Page(s) 26–29

    Language English
    Publishing date 2021-08-30
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2657644-2
    ISSN 2046-2484
    ISSN 2046-2484
    DOI 10.1002/cld.1106
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Conference proceedings: [No title information]

    Erdemir, Gizem / Gökcan, Hale / Idilman, Ramazan

    Zeitschrift für Gastroenterologie

    2023  Volume 61, Issue 01

    Event/congress 39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber, Bochum, 2023-01-27
    Language German
    Publishing date 2023-01-01
    Publisher Georg Thieme Verlag
    Publishing place Stuttgart ; New York
    Document type Article ; Conference proceedings
    ZDB-ID 201387-3
    ISSN 1439-7803 ; 0044-2771 ; 0172-8504
    ISSN (online) 1439-7803
    ISSN 0044-2771 ; 0172-8504
    DOI 10.1055/s-0042-1759988
    Database Thieme publisher's database

    More links

    Kategorien

  5. Article ; Online: Serum biomarkers for the evaluation of liver fibrosis: The need for better tests.

    Zeybel, Müjdat / İdilman, Ramazan

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

    2018  Volume 29, Issue 4, Page(s) 377–378

    MeSH term(s) Biomarkers ; Biopsy ; Humans ; Liver Cirrhosis
    Chemical Substances Biomarkers
    Language English
    Publishing date 2018-09-24
    Publishing country Turkey
    Document type Editorial ; Comment
    ZDB-ID 1340275-4
    ISSN 2148-5607 ; 1300-4948
    ISSN (online) 2148-5607
    ISSN 1300-4948
    DOI 10.5152/tjg.2018.260618
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: NSAID-associated drug-induced liver injury prior to and following liver transplantation.

    Gumussoy, Mesut / Gokcan, Hale / Bodakci, Emin / Kiremitci, Saba / Savas, Berna / Idilman, Ramazan

    Hepatology forum

    2022  Volume 3, Issue 3, Page(s) 108–109

    Language English
    Publishing date 2022-09-23
    Publishing country Turkey
    Document type Journal Article
    ISSN 2757-7392
    ISSN (online) 2757-7392
    DOI 10.14744/hf.2021.2021.0050
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Demonstration of therapy response to radioembolization with

    Ozkan, Elgin / Demir, Burak / Oz, Digdem Kuru / Soydal, Cigdem / Dursun, Ecenur / Celebioglu, Emre Can / Idilman, Ramazan / Kucuk, Nuriye Ozlem

    European journal of nuclear medicine and molecular imaging

    2023  Volume 51, Issue 1, Page(s) 316–317

    MeSH term(s) Humans ; Carcinoma, Hepatocellular/diagnostic imaging ; Carcinoma, Hepatocellular/radiotherapy ; Liver Neoplasms/diagnostic imaging ; Liver Neoplasms/radiotherapy ; Microspheres ; Yttrium Radioisotopes/therapeutic use ; Positron-Emission Tomography ; Magnetic Resonance Imaging ; Embolization, Therapeutic
    Chemical Substances gallium 68 PSMA-11 ; Yttrium Radioisotopes
    Language English
    Publishing date 2023-08-26
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 8236-3
    ISSN 1619-7089 ; 0340-6997 ; 1619-7070
    ISSN (online) 1619-7089
    ISSN 0340-6997 ; 1619-7070
    DOI 10.1007/s00259-023-06413-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A rare disease that presents with acute severe hepatitis: Kikuchi-Fujimoto disease.

    Kartal, Aysun / Melekoglu, Zeynep / Saglam, Arzu / Civriz, Sinem / Idilman, Ramazan

    Hepatology forum

    2020  Volume 1, Issue 1, Page(s) 41–42

    Language English
    Publishing date 2020-01-20
    Publishing country Turkey
    Document type Journal Article
    ISSN 2757-7392
    ISSN (online) 2757-7392
    DOI 10.14744/hf.2020.0007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Immunoglobulin light chain amyloidosis presenting as Budd-Chiari syndrome.

    Ozercan, Mubin / Eser, Irem / Kiremitci, Saba / Peynircioglu, Bora / Karayalcin, Selim / Idilman, Ramazan

    Hepatology forum

    2021  Volume 2, Issue 3, Page(s) 120–121

    Language English
    Publishing date 2021-09-15
    Publishing country Turkey
    Document type Journal Article
    ISSN 2757-7392
    ISSN (online) 2757-7392
    DOI 10.14744/hf.2021.2021.0028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Therapy of Delta Hepatitis.

    Yurdaydin, Cihan / Idilman, Ramazan

    Cold Spring Harbor perspectives in medicine

    2015  Volume 5, Issue 10

    Abstract: Delta hepatitis is the less frequently encountered but most severe form of viral hepatitis. Acute delta hepatitis, as a result of coinfection with hepatitis B and hepatitis delta, is rare, but may lead to fulminant hepatitis, and no therapy exists for ... ...

    Abstract Delta hepatitis is the less frequently encountered but most severe form of viral hepatitis. Acute delta hepatitis, as a result of coinfection with hepatitis B and hepatitis delta, is rare, but may lead to fulminant hepatitis, and no therapy exists for this form. Chronic delta hepatitis (CDH) mostly develops as a result of superinfection of a hepatitis B surface antigen (HBsAg) carrier with hepatitis delta virus (HDV). In general, HDV is the dominant virus. However, a dynamic shift of the dominant virus may occur with time in rare instances, and hepatitis B virus (HBV) may become the dominant virus, at which time nucleos(t)ide analog therapy may be indicated. Otherwise, the only established management of CDH consists of conventional or pegylated interferon therapy, which has to be administered at doses used for hepatitis B for a duration of at least 1 year. Posttreatment week-24 virologic response is the most widely used surrogate marker of treatment efficacy, but it does not represent a sustained virologic response, and late relapse can occur. As an easy-to-use simple serological test, anti-HDV-immunoglobulin M (IgM) correlates with histological inflammatory activity and clinical long-term outcome; however, it is not as sensitive as HDV RNA in assessing treatment response. No evidence-based rules for treating CDH exist, and treatment duration needs to be individualized based on virologic response at end of treatment or end of follow-up. Effective treatment may decrease liver-related complications, such as decompensation or liver-related mortality. In patients with decompensated cirrhosis, interferons are contraindicated and liver transplantation has to be considered. Alternative treatment options are an urgent need in CDH. New treatment strategies targeting different steps of the HDV life cycle, such as hepatocyte entry inhibitors or prenylation inhibitors, are emerging and provide hope for the future.
    MeSH term(s) Acute Disease ; Antiviral Agents/therapeutic use ; Controlled Clinical Trials as Topic ; Drug Therapy, Combination ; Drugs, Investigational/therapeutic use ; Hepatitis D/drug therapy ; Hepatitis D, Chronic/drug therapy ; Humans ; Interferons/therapeutic use ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/virology ; Nucleosides/therapeutic use ; Nucleotides/therapeutic use
    Chemical Substances Antiviral Agents ; Drugs, Investigational ; Nucleosides ; Nucleotides ; Interferons (9008-11-1)
    Language English
    Publishing date 2015-08-07
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2157-1422
    ISSN (online) 2157-1422
    DOI 10.1101/cshperspect.a021543
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top